Bekir Bediz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bekir Bediz has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- O. Burak Ozdoganlar
Department of Mechanical Engineering Carnegie Mellon University Pittsburgh PA 15213 USA
12 shared publications Emrullah Korkmaz
6 shared publications- Peiman Khandar Shahabad
Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey
6 shared publications Ipek Basdogan
4 shared publicationsMirmeysam Rafiei Anamagh
4 shared publications- Mirmeysam Rafiei Anamagh
Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey
4 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by Elsevier in Composite Structures
- Vol. 395
Vibrational analysis of carbon fibre composite structures containing randomly distributed graphene platelets using a three-dimensional spectral element method
- 17 August 2026
- Published by Elsevier in Composite Structures
- Vol. 395
Open AccessVibrational analysis of carbon fibre composite structures containing randomly distributed graphene platelets using a three-dimensional spectral element method
- 20 May 2026
- Published by Elsevier in Composite Structures
- Vol. 390
A Multi-Objective Mixed-variable Co-evolutionary Genetic Programming approach for stiffened composite panel design
- 20 May 2026
- Published by Elsevier in Composite Structures
- Vol. 390
A Multi-Objective Mixed-variable Co-evolutionary Genetic Programming approach for stiffened composite panel design
- Open Access
- 15 May 2026
- Published by Elsevier in CIRP Annals
- Vol. 75 (1) , 143-147
Tchebychev-based modal-domain coupling (TMDC) for prediction of microtool-tip dynamics
- 15 May 2026
- Published by Elsevier in CIRP Annals
- Vol. 75 (1) , 143-147
Open AccessTchebychev-based modal-domain coupling (TMDC) for prediction of microtool-tip dynamics
- 21 August 2025
- Published by Elsevier in Thin-Walled Structures
- Vol. 217
Predicting workpiece dynamics in milling of thin-walled structures using three-dimensional spectral element method
- 21 August 2025
- Published by Elsevier in Thin-Walled Structures
- Vol. 217
Predicting workpiece dynamics in milling of thin-walled structures using three-dimensional spectral element method
- 3 April 2025
- Published by Springer Nature in Journal of Mechanical Science and Technology
- Vol. 39 (4) , 2015-2027
Integrated design optimization of a motorized active magnetic bearing spindle for micro-milling applications
- 3 April 2025
- Published by Springer Nature in Journal of Mechanical Science and Technology
- Vol. 39 (4) , 2015-2027
Integrated design optimization of a motorized active magnetic bearing spindle for micro-milling applications
- 12 September 2024
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 36 (1) , 64-85
Design of poly(vinyl pyrrolidone) and poly(ethylene glycol) microneedle arrays for delivering glycosaminoglycan, chondroitin sulfate, and hyaluronic acid
Diabetes mellitus (DM) is a multifactorial life-threatening endocrine disease characterized by abnormalities in glucose metabolism. It is a chronic metabolic disease that involves multiple enzymes such as alpha-amylase and alpha-glucosidases. Inhibition of these enzymes has been identified as a promising method for managing diabetes, and researchers are currently focusing on discovering novel alpha-amylase and alpha-glucosidase inhibitors for diabetes therapy. Hence, we have selected 12 bioactive compounds from the Momordica charantia (MC) plant and performed a virtual screening and molecular dynamics investigation to identify natural inhibitors of alpha-amylase and alpha-glucosidases. Our in silico result revealed that phytocompound Rutin showed the highest binding affinity against alpha-amylase (1HNY) enzymes at (-11.68 kcal/mol), followed by Karaviloside II (-9.39), Momordicoside F (-9.19), Campesterol (-9.11. While docking against alpha-glucosidases (4J5T), Rutin again showed the greatest binding affinity (-11.93 kcal/mol), followed by Momordicine (-9.89), and Campesterol (-8.99). Molecular dynamics (MD) simulation research is currently the gold standard for drug design and discovery. Consequently, we conducted simulations of 100 nanoseconds (ns) to assess the stability of protein-ligand complexes based on parameters like RMSD, RMSF, RG, PCA, and FEL. The significance of our findings indicates that rutin from MC might serve as an effective natural therapeutic agent for diabetes management due to its strongest binding affinities with alpha-amylase and alpha-glucosidase enzymes. Further research in animals and humans is essential to validate the efficacy of these drug molecules.
- 12 September 2024
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 36 (1) , 64-85
Design of poly(vinyl pyrrolidone) and poly(ethylene glycol) microneedle arrays for delivering glycosaminoglycan, chondroitin sulfate, and hyaluronic acid
Diabetes mellitus (DM) is a multifactorial life-threatening endocrine disease characterized by abnormalities in glucose metabolism. It is a chronic metabolic disease that involves multiple enzymes such as alpha-amylase and alpha-glucosidases. Inhibition of these enzymes has been identified as a promising method for managing diabetes, and researchers are currently focusing on discovering novel alpha-amylase and alpha-glucosidase inhibitors for diabetes therapy. Hence, we have selected 12 bioactive compounds from the Momordica charantia (MC) plant and performed a virtual screening and molecular dynamics investigation to identify natural inhibitors of alpha-amylase and alpha-glucosidases. Our in silico result revealed that phytocompound Rutin showed the highest binding affinity against alpha-amylase (1HNY) enzymes at (-11.68 kcal/mol), followed by Karaviloside II (-9.39), Momordicoside F (-9.19), Campesterol (-9.11. While docking against alpha-glucosidases (4J5T), Rutin again showed the greatest binding affinity (-11.93 kcal/mol), followed by Momordicine (-9.89), and Campesterol (-8.99). Molecular dynamics (MD) simulation research is currently the gold standard for drug design and discovery. Consequently, we conducted simulations of 100 nanoseconds (ns) to assess the stability of protein-ligand complexes based on parameters like RMSD, RMSF, RG, PCA, and FEL. The significance of our findings indicates that rutin from MC might serve as an effective natural therapeutic agent for diabetes management due to its strongest binding affinities with alpha-amylase and alpha-glucosidase enzymes. Further research in animals and humans is essential to validate the efficacy of these drug molecules.